Cargando…
The Role of Capsid in HIV-1 Nuclear Entry
HIV-1 can infect non-dividing cells. The nuclear envelope therefore represents a barrier that HIV-1 must traverse in order to gain access to the host cell chromatin for integration. Hence, nuclear entry is a critical step in the early stages of HIV-1 replication. Following membrane fusion, the viral...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402913/ https://www.ncbi.nlm.nih.gov/pubmed/34452291 http://dx.doi.org/10.3390/v13081425 |
_version_ | 1783745905137025024 |
---|---|
author | Guedán, Anabel Caroe, Eve R. Barr, Genevieve C. R. Bishop, Kate N. |
author_facet | Guedán, Anabel Caroe, Eve R. Barr, Genevieve C. R. Bishop, Kate N. |
author_sort | Guedán, Anabel |
collection | PubMed |
description | HIV-1 can infect non-dividing cells. The nuclear envelope therefore represents a barrier that HIV-1 must traverse in order to gain access to the host cell chromatin for integration. Hence, nuclear entry is a critical step in the early stages of HIV-1 replication. Following membrane fusion, the viral capsid (CA) lattice, which forms the outer face of the retroviral core, makes numerous interactions with cellular proteins that orchestrate the progress of HIV-1 through the replication cycle. The ability of CA to interact with nuclear pore proteins and other host factors around the nuclear pore determines whether nuclear entry occurs. Uncoating, the process by which the CA lattice opens and/or disassembles, is another critical step that must occur prior to integration. Both early and delayed uncoating have detrimental effects on viral infectivity. How uncoating relates to nuclear entry is currently hotly debated. Recent technological advances have led to intense discussions about the timing, location, and requirements for uncoating and have prompted the field to consider alternative uncoating scenarios that presently focus on uncoating at the nuclear pore and within the nuclear compartment. This review describes recent advances in the study of HIV-1 nuclear entry, outlines the interactions of the retroviral CA protein, and discusses the challenges of investigating HIV-1 uncoating. |
format | Online Article Text |
id | pubmed-8402913 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-84029132021-08-29 The Role of Capsid in HIV-1 Nuclear Entry Guedán, Anabel Caroe, Eve R. Barr, Genevieve C. R. Bishop, Kate N. Viruses Review HIV-1 can infect non-dividing cells. The nuclear envelope therefore represents a barrier that HIV-1 must traverse in order to gain access to the host cell chromatin for integration. Hence, nuclear entry is a critical step in the early stages of HIV-1 replication. Following membrane fusion, the viral capsid (CA) lattice, which forms the outer face of the retroviral core, makes numerous interactions with cellular proteins that orchestrate the progress of HIV-1 through the replication cycle. The ability of CA to interact with nuclear pore proteins and other host factors around the nuclear pore determines whether nuclear entry occurs. Uncoating, the process by which the CA lattice opens and/or disassembles, is another critical step that must occur prior to integration. Both early and delayed uncoating have detrimental effects on viral infectivity. How uncoating relates to nuclear entry is currently hotly debated. Recent technological advances have led to intense discussions about the timing, location, and requirements for uncoating and have prompted the field to consider alternative uncoating scenarios that presently focus on uncoating at the nuclear pore and within the nuclear compartment. This review describes recent advances in the study of HIV-1 nuclear entry, outlines the interactions of the retroviral CA protein, and discusses the challenges of investigating HIV-1 uncoating. MDPI 2021-07-22 /pmc/articles/PMC8402913/ /pubmed/34452291 http://dx.doi.org/10.3390/v13081425 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Guedán, Anabel Caroe, Eve R. Barr, Genevieve C. R. Bishop, Kate N. The Role of Capsid in HIV-1 Nuclear Entry |
title | The Role of Capsid in HIV-1 Nuclear Entry |
title_full | The Role of Capsid in HIV-1 Nuclear Entry |
title_fullStr | The Role of Capsid in HIV-1 Nuclear Entry |
title_full_unstemmed | The Role of Capsid in HIV-1 Nuclear Entry |
title_short | The Role of Capsid in HIV-1 Nuclear Entry |
title_sort | role of capsid in hiv-1 nuclear entry |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402913/ https://www.ncbi.nlm.nih.gov/pubmed/34452291 http://dx.doi.org/10.3390/v13081425 |
work_keys_str_mv | AT guedananabel theroleofcapsidinhiv1nuclearentry AT caroeever theroleofcapsidinhiv1nuclearentry AT barrgenevievecr theroleofcapsidinhiv1nuclearentry AT bishopkaten theroleofcapsidinhiv1nuclearentry AT guedananabel roleofcapsidinhiv1nuclearentry AT caroeever roleofcapsidinhiv1nuclearentry AT barrgenevievecr roleofcapsidinhiv1nuclearentry AT bishopkaten roleofcapsidinhiv1nuclearentry |